Optimal weighted Bonferroni tests and their graphical extensions

Author:

Xi Dong1ORCID,Chen Yao2ORCID

Affiliation:

1. Gilead Sciences Foster City California USA

2. Novartis Pharmaceuticals Corporation East Hanover New Jersey USA

Abstract

Regulatory guidelines mandate the strong control of the familywise error rate in confirmatory clinical trials with primary and secondary objectives. Bonferroni tests are one of the popular choices for multiple comparison procedures and are building blocks of more advanced procedures. It is usually of interest to find the optimal weighted Bonferroni split for multiple hypotheses. We consider two popular quantities as the optimization objectives, which are the disjunctive power and the conjunctive power. The former is the probability to reject at least one false hypothesis and the latter is the probability to reject all false hypotheses. We investigate the behavior of each of them as a function of different Bonferroni splits, given assumptions about the alternative hypotheses and correlations between test statistics. Under independent tests, unique optimal Bonferroni weights exist; under dependence, optimal Bonferroni weights may not be unique based on a fine grid search. In general, we propose an optimization algorithm based on constrained nonlinear optimization and multiple starting points. The proposed algorithm efficiently identifies optimal Bonferroni weights to maximize the disjunctive or conjunctive power. In addition, we apply the proposed algorithm to graphical approaches, which include many Bonferroni‐based multiple comparison procedures. Utilizing the closed testing principle, we adopt a two‐step approach to find optimal graphs using the disjunctive power. We also identify a class of closed test procedures that optimize the conjunctive power. We apply the proposed algorithm to a case study to illustrate the utility of optimal graphical approaches that reflect study objectives.

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference48 articles.

1. Guideline on multiplicity issues in clinical trials (Draft).https://www.ema.europa.eu/en/documents/scientific‐guideline/draft‐guideline‐multiplicity‐issues‐clinical‐trials_en.pdf;2017. Accessed May 24 2023.

2. Multiple endpoints in clinical trials Guidance for industry.https://www.fda.gov/regulatory‐information/search‐fda‐guidance‐documents/multiple‐endpoints‐clinical‐trials‐guidance‐industry;2022. Accessed May 24 2023.

3. A graphical approach to sequentially rejective multiple test procedures

4. A recycling framework for the construction of Bonferroni-based multiple tests

5. Memory and other properties of multiple test procedures generated by entangled graphs

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3